LGM

Logos Global Management Portfolio holdings

AUM $749M
This Quarter Return
+9.87%
1 Year Return
+18.94%
3 Year Return
+431.72%
5 Year Return
+481.1%
10 Year Return
AUM
$893M
AUM Growth
+$24.8M
Cap. Flow
-$12.7M
Cap. Flow %
-1.42%
Top 10 Hldgs %
48.42%
Holding
67
New
14
Increased
9
Reduced
18
Closed
12
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
IOBT icon
51
IO Biotech
IOBT
$115M
$519K 0.06%
493,827
SKYE icon
52
Skye Bioscience
SKYE
$104M
$391K 0.04%
100,000
-1,201,518
-92% -$4.7M
BOLD
53
Boundless Bio
BOLD
$25.7M
$204K 0.02%
58,903
-58,903
-50% -$204K
APLS icon
54
Apellis Pharmaceuticals
APLS
$3.51B
-400,000
Closed -$15.3M
APLT icon
55
Applied Therapeutics
APLT
$73.7M
-600,000
Closed -$2.66M
ARGX icon
56
argenx
ARGX
$44.2B
-135,000
Closed -$58.1M
BHVN icon
57
Biohaven
BHVN
$1.71B
-250,000
Closed -$8.68M
ELEV
58
DELISTED
Elevation Oncology
ELEV
-3,850,000
Closed -$10.4M
FULC icon
59
Fulcrum Therapeutics
FULC
$353M
0
MLTX icon
60
MoonLake Immunotherapeutics
MLTX
$3.78B
-750,000
Closed -$33M
NUVB.WS icon
61
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$63.9M
-66,666
Closed -$10.7K
RLAY icon
62
Relay Therapeutics
RLAY
$709M
-1,300,000
Closed -$8.48M
RNAC icon
63
Cartesian Therapeutics
RNAC
$267M
-90,000
Closed -$2.43M
STOK icon
64
Stoke Therapeutics
STOK
$1.08B
-1,050,000
Closed -$14.2M
XBI icon
65
SPDR S&P Biotech ETF
XBI
$5.29B
0
XENE icon
66
Xenon Pharmaceuticals
XENE
$2.99B
-375,000
Closed -$14.6M
XNCR icon
67
Xencor
XNCR
$594M
-1,500,000
Closed -$28.4M